杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Nov 24 2020

Full Issue

Delivery Begins Of Regeneron's Antibody Treatment After FDA OK

The Trump administration says it will start today distributing the COVID-19 therapy, just approved for emergency use by the FDA. Meanwhile a former FDA chief warns about the virus' long-term effects.

The federal government will begin distributing doses of Regeneron's antibody drug treatment for COVID-19 on Tuesday, top health officials said.聽During a call with reporters, Health and Human Services (HHS) Secretary Alex Azar said the administration will distribute 30,000 doses of the drug, with more coming in the weeks ahead.聽The company expects to produce 300,000 doses by early January. (Weixel, 11/23)

Health experts do not know the long term effects of COVID-19, and former Food and Drug Administration (FDA) Commissioner Scott Gottlieb said he is concerned they could be serious. "I'm worried about it. I don't think we fully understand what these syndromes are," Gottlieb said during a discussion at the American Enterprise Institute. (Weixel, 11/23)

In other news from the Trump administration 鈥

Surgeon General Jerome Adams on Monday warned Americans to avoid indoor holiday celebrations with people they don't live with, including parties being planned by the White House. During an appearance on ABC's 鈥淕ood Morning America,鈥 Adams said events like the planned White House holiday parties are a cause for concern. (Weixel, 11/23)

The White House is going ahead with plans to hold holiday parties and receptions at the presidential mansion despite a surge in coronavirus cases and warnings from public health officials to avoid large in-person gatherings. Invitations for the indoor holiday events, which are scheduled to start next week, already have been sent out. An invitation to a Dec. 1 reception 鈥 a copy of which was obtained by USA TODAY 鈥 makes no mention of mandatory face masks or social distancing requirements. (Collins and Puente, 11/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 17
  • Tuesday, June 16
  • Monday, June 15
  • Friday, June 12
  • Thursday, June 11
  • Wednesday, June 10
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF